@article{3119542,
    title = "Delayed-onset severe neurotoxicity related to blinatumomab in an adolescent patient with refractory acute lymphoblastic leukemia",
    author = "Filippidou, M. and Avgerinou, G. and Katsibardi, K. and Gavra, M. and Pons, R. and Kattamis, A.",
    journal = "Pediatric Blood and Cancer",
    year = "2021",
    volume = "68",
    number = "7",
    publisher = "John Wiley and Sons Inc",
    issn = "1545-5009, 1545-5017",
    doi = "10.1002/pbc.29040",
    keywords = "blinatumomab;  clofarabine;  clonidine;  cyclophosphamide;  cytarabine;  dexamethasone;  diazepam;  etoposide;  fludarabine;  haloperidol;  immunoglobulin;  methotrexate;  methylprednisolone;  midazolam;  phenobarbital;  risperidone;  antineoplastic agent;  bispecific antibody;  blinatumomab, acute lymphoblastic leukemia;  adolescent;  artificial ventilation;  automutilation;  bone marrow cell;  cancer chemotherapy;  cancer patient;  cancer resistance;  case report;  cell count;  clinical article;  clinical feature;  diffusion weighted imaging;  disease severity;  dysarthria;  electroencephalography;  epileptic discharge;  epileptic state;  female;  fluid-attenuated inversion recovery imaging;  human;  hypertension;  Letter;  minimal residual disease;  neurotoxicity;  nuclear magnetic resonance imaging;  parental consent;  pre B lymphocyte;  tonic clonic seizure;  treatment duration;  treatment response, Adolescent;  Antibodies, Bispecific;  Antineoplastic Agents;  Humans;  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;  Precursor Cell Lymphoblastic Leukemia-Lymphoma"
}